This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland
BOOK NOW
Menu
BOOK NOW

Dr. Kathryn (Kate) Monroe, PhD
Director and Principal Scientist at Denali Therapeutics
Speaker

At this event

Prev
Next
Jane Osbourn, PhD
CEO
Alchemab Therapeutics

See Kathryn (Kate) at Antibody Engineering & Therapeutics Europe

BOOK NOW